Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198940 | SCV000250592 | likely benign | not provided | 2019-10-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311057 | SCV000320324 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-11-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003761818 | SCV001003373 | benign | FG syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000198940 | SCV004699060 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | MED12: PP2, BP4, BS2 |
Prevention |
RCV003985304 | SCV004742206 | likely benign | MED12-related disorder | 2021-10-07 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |